Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice.
Reactivation of human cytomegalovirus (HCMV) can cause severe disease in recipients of hematopoietic stem cell transplantation. Although preclinical research in murine models as well as clinical trials have provided 'proof of concept' for infection control by pre-emptive CD8 T-cell immunot...
Main Authors: | Simone Thomas, Sebastian Klobuch, Jürgen Podlech, Bodo Plachter, Petra Hoffmann, Angelique Renzaho, Matthias Theobald, Matthias J Reddehase, Wolfgang Herr, Niels A W Lemmermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-07-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC4504510?pdf=render |
Similar Items
-
The p36 Isoform of Murine Cytomegalovirus m152 Protein Suffices for Mediating Innate and Adaptive Immune Evasion
by: Annette Fink, et al.
Published: (2013-12-01) -
Host-Adapted Gene Families Involved in Murine Cytomegalovirus Immune Evasion
by: Sara Becker, et al.
Published: (2022-01-01) -
Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection
by: Kerstin M. Gergely, et al.
Published: (2021-08-01) -
Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread
by: Rafaela Holtappels, et al.
Published: (2022-05-01) -
Revisiting CD8 T-cell ‘Memory Inflation’: New Insights with Implications for Cytomegaloviruses as Vaccine Vectors
by: Rafaela Holtappels, et al.
Published: (2020-07-01)